ArticleDrug design, development and therapy2017

A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.

Seunghoon Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.